This inventor holds 44 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 22 EPO patents, primarily in Therapeutic Compounds. Top assignees: Xenon Pharmaceuticals Inc., Genentech, Inc., Novartis Ag. Active years: 2008-2022.
Location History:
- Scarborough, CA (2008 - 2011)
- Burnaby, CA (2015 - 2021)
- Surrey, CA (2010 - 2022)
Company Filing History:
43 out of 110 
17 out of 3,292 
2 out of 3,973 
Years Active: 2008-2022
Areas of Expertise:
Title: **Sultan Chowdhury: Innovator in Therapeutic Chemistry**
Introduction
Sultan Chowdhury, located in Surrey, Canada, is a prolific inventor with an impressive portfolio of 44 patents. His work primarily focuses on the development of therapeutic agents, underscoring his commitment to advancing medical science through innovative chemical compounds.
Latest Patents
Among Chowdhury's recent contributions are two notable patents. The first, titled "Benzenesulfonamide Compounds and Their Use as Therapeutic Agents," involves the development of benzenesulfonamide compounds, including their stereoisomers and derivatives. These compounds are particularly relevant for treating diseases associated with voltage-gated sodium channels, such as epilepsy. The second patent, "Substituted Benzamides and Methods of Use Thereof," describes a range of compounds characterized by a general formula and their pharmaceutically acceptable salts. This invention also emphasizes the applications of these compounds in medical treatments.
Career Highlights
Chowdhury has made significant contributions to the pharmaceutical industry through his work at reputable organizations. He has held positions at Xenon Pharmaceuticals Inc. and Genentech, Inc., where he collaborated on various innovative projects that align with his research interests in therapeutic chemistry.
Collaborations
Throughout his career, Sultan has worked alongside esteemed professionals, including his colleagues Shaoyi Sun and Christoph Martin Dehnhardt. These collaborations reflect a synergistic approach to research and development, fostering an environment of innovation and scientific discovery.
Conclusion
Sultan Chowdhury’s dedication to the field of therapeutic agents is evident through his extensive patent portfolio and collaborative efforts. His innovative spirit and expertise continue to have a positive impact on healthcare and the treatment of critical medical conditions. As he progresses in his career, his contributions to chemistry and pharmacology are sure to inspire future advancements in the field.